--2025/Q1-- / 154.160K--
--2024/Q4-- / 102.930K--
--2024/Q343.000K / 205.400K--
--2024/Q2111.000K / 176.330K--
--2024/Q1529.000K / 0.000--
Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
CGON CG Oncology
- 30.460
- -0.550-1.77%
Close Jan 8 16:00 ET
- 31.870
- +1.410+4.63%
Pre 04:39 ET
2.28BMarket Cap-26.12P/E (TTM)
30.900High30.150Low740.02KVolume30.710Open31.010Pre Close22.58MTurnover1.37%Turnover RatioLossP/E (Static)74.93MShares50.23052wk High4.25P/B1.65BFloat Cap25.77052wk Low--Dividend TTM54.12MShs Float50.230Historical High--Div YieldTTM2.42%Amplitude25.770Historical Low30.510Avg Price1Lot Size
CG Oncology Key Stats
CG Oncology Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
CG Oncology Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data